Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT06597201
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Chengdu Qingshan Likang Pharmaceutical Co., Ltd
- Registry
-
NCT06597201
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06597201. Randomized; no masking; primary purpose treatment. Start 2024-08-09 (actual); primary completion 2025-06-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
- Condition
- End Stage Renal Disease (ESRD)
- Intervention (Drug)
- amino acid (15) peritoneal dialysis solution
- Intervention (Drug)
- glucose peritoneal dialysis solution
- Lead sponsor
- Chengdu Qingshan Likang Pharmaceutical Co., Ltd
Record details
- Record id
cardio:ct-nct06597201- Content hash
83e8004ae2f79b415f8cdc82c0004d6324b55fc09c96982e43f12051b1c5e6df